Invention Grant
- Patent Title: Preparation method for ecteinascidin compound and intermediate thereof
-
Application No.: US17283012Application Date: 2019-08-26
-
Publication No.: US12122784B2Publication Date: 2024-10-22
- Inventor: Jiandong Yuan , Xinliang Fu , Zhanli Sun , Xiaopei Xing , Jingcheng Hui , Qilei Cong
- Applicant: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
- Applicant Address: CN Suzhou
- Assignee: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
- Current Assignee: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: DINSMORE & SHOHL LLP
- Priority: CN 1910101895.0 2019.02.01
- International Application: PCT/CN2019/102565 2019.08.26
- International Announcement: WO2020/155613A 2020.08.06
- Date entered country: 2021-04-05
- Main IPC: C07D487/18
- IPC: C07D487/18 ; C07D515/22

Abstract:
The present invention provides a method for preparing an ecteinascidin compound and an intermediate thereof, and specifically provides a preparation method for a novel compound QT9, and a method of using QT9 to prepare an ecteinascidin compound. The method provided by the present invention has high reaction selectivity and high yield, the obtained compound is easy to purify, and defects in the prior art that multiple intermediates are oily substances, and the reaction selectivity is poor are solved. The method of the present invention is particularly applicable to industrial production.
Public/Granted literature
- US20210355132A1 PREPARATION METHOD FOR ECTEINASCIDIN COMPOUND AND INTERMEDIATE THEREOF Public/Granted day:2021-11-18
Information query